Arch Historical Cash Flow
| ARCH Stock | CAD 1.84 0.01 0.55% |
Analysis of Arch Biopartners cash flow over time is an excellent tool to project Arch Biopartners future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 253.2 K or Begin Period Cash Flow of 611.4 K as it is a great indicator of Arch Biopartners ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Arch Biopartners latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Arch Biopartners is a good buy for the upcoming year.
Arch |
About Arch Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Arch balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Arch's non-liquid assets can be easily converted into cash.
Arch Biopartners Cash Flow Chart
Add Fundamental
Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Arch Biopartners' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Arch Biopartners current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arch Biopartners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. At this time, Arch Biopartners' Change In Cash is fairly stable compared to the past year. Change In Working Capital is likely to climb to about 253.2 K in 2024, whereas Depreciation is likely to drop slightly above 48.6 K in 2024.
Arch Biopartners cash flow statement Correlations
Click cells to compare fundamentals
Arch Biopartners Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Arch Biopartners cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 253.3K | (205.4K) | 58.1K | 324.9K | 373.7K | 392.3K | |
| Free Cash Flow | (1.9M) | (3.0M) | (1.1M) | (234.1K) | (210.7K) | (221.2K) | |
| Begin Period Cash Flow | 400.4K | 653.7K | 448.2K | 506.3K | 582.3K | 611.4K | |
| Other Cashflows From Financing Activities | 976K | 2.2M | (16.3K) | 1.4M | 1.6M | 1.7M | |
| Other Non Cash Items | 996.7K | (1.9M) | (25.0K) | 1.1M | 1.3M | 1.4M | |
| Total Cash From Operating Activities | (1.9M) | (3.0M) | (1.1M) | (234.1K) | (210.7K) | (221.2K) | |
| Net Income | (4.6M) | (1.2M) | (1.1M) | (3.3M) | (3.0M) | (2.8M) | |
| Total Cash From Financing Activities | 2.2M | 2.8M | (421.4K) | 559K | 642.9K | 907.9K | |
| End Period Cash Flow | 653.7K | 448.2K | 506.3K | 831.3K | 956.0K | 1.0M | |
| Stock Based Compensation | 1.7M | 109.6K | 25.0K | 2.0M | 2.3M | 2.4M | |
| Net Borrowings | 1.4M | 488K | 1.7M | (791.3K) | (910.0K) | (864.5K) | |
| Change To Netincome | 288.1K | 2.7M | (1.8M) | 1.9M | 2.2M | 2.3M | |
| Issuance Of Capital Stock | 1.7M | 1.0M | 369.9K | 128K | 115.2K | 109.4K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arch Stock Analysis
When running Arch Biopartners' price analysis, check to measure Arch Biopartners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arch Biopartners is operating at the current time. Most of Arch Biopartners' value examination focuses on studying past and present price action to predict the probability of Arch Biopartners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arch Biopartners' price. Additionally, you may evaluate how the addition of Arch Biopartners to your portfolios can decrease your overall portfolio volatility.